Fyperix Combo 67 mg/ 60.3 mg Spot-on Solution for Small Dogs

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: VMD (Veterinary Medicines Directorate)

Aktif bileşen:

(S)-Methoprene, Fipronil

Mevcut itibaren:

Krka d.d., Novo Mesto

ATC kodu:

QP53AX65

INN (International Adı):

(S)-Methoprene, Fipronil

Farmasötik formu:

Spot-on solution

Reçete türü:

POM-V - Prescription Only Medicine – Veterinarian

Terapötik grubu:

Dogs

Terapötik alanı:

Ectoparasiticide; Insect Growth Regulator

Yetkilendirme durumu:

Expired

Yetkilendirme tarihi:

2016-05-04

Ürün özellikleri

Revised: October 2017
AN: 00710/2017
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
FYPERIX combo 67 mg/ 60.3 mg spot-on solution for small dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.67 ml pipette contains:
ACTIVE SUBSTANCE:
Fipronil
67 mg
S-Methoprene
60.3 mg
EXCIPIENTS:
Butylhydroxyanisole (E320)
0.134 mg
Butylhydroxytoluene (E321)
0.067 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs 2-10 kg
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs, dosage defined by bodyweight grouping
(refer to section
4.9):
-
To be used against infestations with fleas, alone or in association
with ticks
and/or biting lice.
-
Treatment of flea infestations (_Ctenocephalides_ spp.). Insecticidal
efficacy
against new infestations with adult fleas persists for 8 weeks.
Prevention of the
multiplication of fleas by inhibiting the development of eggs
(ovicidal activity) and
larvae and pupae (larvicidal activity) originating from eggs laid by
adult fleas for eight
weeks after application.
-
Treatment of tick infestations (_Ixodes ricinus, Dermacentor
variabilis, _
_Dermacentor reticulatus, Rhipicephalus sanguineus_). The product has
persistent
acaricidal efficacy for up to 4 weeks against ticks.
-
Treatment of infestations with biting lice (_Trichodectes canis_).
The product can be used as part of a treatment strategy for the
control of Flea Allergy
Dermatitis (FAD), where this has been previously diagnosed by a
veterinary surgeon.
Revised: October 2017
AN: 00710/2017
Page 2 of 6
4.3
CONTRAINDICATIONS
In the absence of available data, the product should not be used on
puppies less
than 8 weeks old and/or weighing less than 2 kg.
Do not use on sick (e.g. systemic diseases, fever) or convalescent
animals.
DO NOT USE IN RABBITS DUE TO A RISK OF ADVERSE REACTIONS OR EVEN
DEATH.
This product is specifically developed for dogs. Do not use in ca